
Viveve Medical VIVE
Quarterly report 2022-Q3
added 11-10-2022
Viveve Medical Interest Expense 2011-2026 | VIVE
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 M | 910 K | 4.35 M | 4.37 M | 3.17 M | 1.37 M | 415 K | 567 K | 447 K | 555 K | 396 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.37 M | 396 K | 1.6 M |
Quarterly Interest Expense Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 292 K | 284 K | 270 K | - | 255 K | 245 K | 234 K | - | 235 K | 223 K | 210 K | - | 1.21 M | 1.19 M | 1.12 M | - | 1.11 M | 1.06 M | 1.07 M | - | 777 K | 1.34 M | 263 K | - | 221 K | 765 K | 108 K | - | 114 K | 105 K | 83 K | - | 152 K | 71 K | 176 K | - | 157 K | 61 K | 140 K | - | 137 K | 116 K | 116 K | - | 116 K | 115 K | 46 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.34 M | 46 K | 394 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 187.53 | 0.54 % | $ 14 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 291.34 | -1.6 % | $ 8.22 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.12 | -0.91 % | $ 5.83 K | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.48 | -1.34 % | $ 1.69 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.55 | 0.85 % | $ 133 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 64.77 | 0.26 % | $ 95.9 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 10.46 | - | $ 296 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
78 K | $ 25.88 | 0.66 % | $ 219 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.49 | -2.04 % | $ 410 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 93.94 | -0.62 % | $ 12.7 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.92 | -1.03 % | $ 1.17 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 5.04 | 3.6 % | $ 1.07 B | ||
|
Inogen
INGN
|
2.44 M | $ 6.2 | - | $ 165 M | ||
|
LENSAR
LNSR
|
636 K | $ 6.22 | -0.56 % | $ 74.4 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.76 | -2.09 % | $ 385 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 56.25 | -0.72 % | $ 1.65 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 39.15 | -0.79 % | $ 1.22 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 65.23 | 0.14 % | $ 3.56 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 87.02 | -0.9 % | $ 3.02 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.8 | 0.16 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 77.81 | -0.49 % | $ 45.5 B | ||
|
Penumbra
PEN
|
893 K | $ 332.81 | 0.12 % | $ 13 B |